KDM4A and cancer: Most notably, SCFFbxo22-KDM4A is essential for SASP induction and could therefore be a promising candidate for the development of drugs targeting cancer as well as geriatric diseases, since cytokines and growth factors secreted from senescent cells have recently been implicated in chronic inflammation and various age-related changes, including carcinogenesis in vivo7, 37, 38.